Skip to content
Home/Companies/HealthTech/Predilepsy
Predilepsy

Predilepsy

HealthTech·France·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Predilepsy?

Predilepsy is a French HealthTech company, currently owned by Elaia Partners since 2021.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Elaia Partners
Investor
Elaia Partners
Elaia Endowment Fund · 2020 · VC

Key facts

HQFrance
SectorHealthTech
Websitewww.predilepsy.org

More from Elaia Endowment Fund

Other portfolio companies in the same fund.

QBio JRC
Active
BiotechFrance· 2022
Sensation Quantique
Sensation Quantique
Active
HealthTechFrance· 2022
Pyronear
Pyronear
Active
AI/MLFrance· 2021
Institut Analgesia
Institut Analgesia
Active
HealthTechFrance· 2020

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Predilepsy?

Predilepsy is currently owned by Elaia Partners, through Elaia Endowment Fund, since 2021.

When did Elaia Partners acquire Predilepsy?

Elaia Partners acquired Predilepsy in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue